Clinical trial
Intralumenal Effects on Cholesterol Absorption/Synthesis
NCT00328211 · Children's Hospital Medical Center, Cincinnati, Other · Completed
Key facts
| NCT number | NCT00328211 |
|---|---|
| Title | Intralumenal Effects on Cholesterol Absorption/Synthesis |
| Official title | Intralumenal Effects on Cholesterol Absorption/Synthesis |
| Lead sponsor | Children's Hospital Medical Center, Cincinnati, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Dietary Supplement, Other |
| Interventions | Bile Acids (Cholic, Ursodeoxycholic, Chenodeoxycholic), Sphingomyelin, C13 Stable isotope of Cholesterol |
| Enrollment | 35 |
| Start date | Sep 1, 2005 |
| Primary completion | Dec 1, 2013 |
| Completion | Dec 1, 2013 |
| First posted | May 19, 2006 |
| Last update posted | Sep 10, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: